Article
Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression.
Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Sir Y.K. Pao Center for Cancer, Shatin, N.T., Hong Kong, China.
Cancer Letters (impact factor:
4.24).
04/2004;
205(1):81-8.
DOI:10.1016/j.canlet.2003.09.035
pp.81-8
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Accumulation of the pro-apoptotic factor Bak is controlled by antagonist factor Mcl-1 availability.
[show abstract] [hide abstract]
ABSTRACT: Apoptosis has become recognized as a crucial mechanism involved in a wide range of physiological and pathological processes. Following an initial pro-apoptotic signal, controlling phases allow the cell to reinforce or downgrade signals leading to the irrevocable entry into apoptosis. Bak (Bcl-2-antagonist killer) is a mitochondrial pore-forming pro-apoptotic effector inhibited through titration by the anti-apoptotic protein Mcl-1 (Myeloid cell leukemia-1). Viruses have taken advantage of proteasome-dependent degradation of Bak as a mechanism to prevent apoptosis in infected cells. It is not clear however whether regulation of Bak protein level is involved in other physiological processes. In this report, we show that Mcl-1 level is paralleled by Bak while a Mcl-1 non-interacting mutant of Bak does not accumulate in cells. This mechanism is proteasome independent. Following serum withdrawal, Bak accumulation becomes independent of Mcl-1 level and cells are sensitized to pro-apoptotic stimuli. Based on these results, we propose that regulation of Mcl-1-Bak steochiometry is a control mechanism used as a checkpoint to prevent or allow entry into apoptosis.APOPTOSIS 07/2006; 11(6):1039-47. · 4.79 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
anti-apoptotic Bcl-2
apoptotic molecules Bak
control cells
E7 oncoproteins
E7-transfected cells
etiological role
expressed HPV 16 E6
HPV 16 oncoproteins E6
human laryngeal cancer
human laryngeal cancer cell lines
human laryngeal cancer cells
human laryngeal carcinoma
Human papillomavirus type 16
inhibiting apoptosis
laryngeal squamous carcinoma cells
pro-apoptotic Bak
transfected cell lines
tumor necrosis factor alpha
two cell lines
various biological processes